• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

丙型肝炎：英国医疗保健与经济负担预测

Hepatitis C: A Projection of the Healthcare and Economic Burden in the UK.

作者信息

Patruni Bhanu, Nolte Ellen

出版信息

Rand Health Q. 2013 Mar 1;3(1):6. eCollection 2013 Spring.

PMID:28083286
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4945231/
Abstract

Work presented in this article sought to assess the healthcare and economic burden of the hepatitis C virus (HCV) infection in the United Kingdom. It used a cohort simulation model to estimate the prevalence of HCV infection in the UK, including the number of persons who live with HCV infection at different disease stages, and the number of deaths that can be attributed to HCV infection through to 2035. It further assessed the healthcare and societal costs that are associated with HCV infection under different scenarios of diagnosis and treatment rates.

摘要

本文所呈现的研究旨在评估英国丙型肝炎病毒（HCV）感染带来的医疗和经济负担。该研究使用了队列模拟模型来估计英国HCV感染的患病率，包括处于不同疾病阶段的HCV感染者数量，以及到2035年可归因于HCV感染的死亡人数。它还进一步评估了在不同诊断和治疗率情况下与HCV感染相关的医疗和社会成本。

相似文献

1
Hepatitis C: A Projection of the Healthcare and Economic Burden in the UK.丙型肝炎：英国医疗保健与经济负担预测
Rand Health Q. 2013 Mar 1;3(1):6. eCollection 2013 Spring.
2
Modeling the fiscal costs and benefits of alternative treatment strategies in the United Kingdom for chronic hepatitis C.模拟英国慢性丙型肝炎替代治疗策略的财政成本与效益。
J Med Econ. 2018 Jan;21(1):19-26. doi: 10.1080/13696998.2017.1371032. Epub 2017 Sep 5.
3
Scenarios to manage the hepatitis C disease burden and associated economic impact of treatment in Turkey.土耳其丙型肝炎疾病负担及治疗相关经济影响的管理方案。
Hepatol Int. 2017 Nov;11(6):509-516. doi: 10.1007/s12072-017-9820-3. Epub 2017 Oct 12.
4
Tackling the burden of the hepatitis C virus in the UK: characterizing and assessing the clinical and economic consequences.解决英国丙型肝炎病毒负担：描述和评估临床及经济后果。
Public Health. 2016 Dec;141:42-51. doi: 10.1016/j.puhe.2016.08.002. Epub 2016 Sep 16.
5
Projecting severe sequelae of injection-related hepatitis C virus epidemic in the UK. Part 2: Preliminary UK estimates of prevalent injection-related hepatitis C carriers, and derivation of progression rates to liver cirrhosis by gender and age at hepatitis C virus infection.预测英国注射相关丙型肝炎病毒流行的严重后遗症。第2部分：英国注射相关丙型肝炎病毒携带者流行率的初步估计，以及按丙型肝炎病毒感染时的性别和年龄推导肝硬化进展率。
J Epidemiol Biostat. 2001;6(3):267-77; discussion 279-85.
6
Projecting severe sequelae of injection-related hepatitis C virus epidemic in the UK. Part 1: Critical hepatitis C and injector data.预测英国注射相关丙型肝炎病毒流行的严重后遗症。第1部分：重症丙型肝炎和注射者数据。
J Epidemiol Biostat. 2001;6(3):243-65; discussion 279-85.
7
Economic burden associated with patients diagnosed with hepatitis C.与丙型肝炎患者相关的经济负担。
Clin Ther. 2011 Sep;33(9):1268-80. doi: 10.1016/j.clinthera.2011.07.008. Epub 2011 Aug 12.
8
Economic burden of hepatitis C in Egypt: the future impact of highly effective therapies.埃及丙型肝炎的经济负担：高效疗法的未来影响。
Aliment Pharmacol Ther. 2015 Sep;42(6):696-706. doi: 10.1111/apt.13316. Epub 2015 Jul 22.
9
Liver Disease Burden of Hepatitis C Virus Infection in Iran and the Potential Impact of Various Treatment Strategies on the Disease Burden.伊朗丙型肝炎病毒感染的肝脏疾病负担以及各种治疗策略对疾病负担的潜在影响。
Hepat Mon. 2016 Jun 14;16(7):e37234. doi: 10.5812/hepatmon.37234. eCollection 2016 Jul.
10
Assessing the burden of illness of chronic hepatitis C and impact of direct-acting antiviral use on healthcare costs in Medicaid.评估慢性丙型肝炎的疾病负担以及直接作用抗病毒药物在医疗补助计划中对医疗成本的影响。
Am J Manag Care. 2019 Jun;25(8 Suppl):S131-S139.

引用本文的文献

1
Budget impact analysis of two treatment approaches for hepatitis C in Malaysia through the use of voluntary and compulsory licensing options.马来西亚使用自愿和强制许可选择治疗丙型肝炎的两种方法的预算影响分析。
Front Public Health. 2023 Feb 22;11:1114560. doi: 10.3389/fpubh.2023.1114560. eCollection 2023.
2
Sick leave and disability pension in patients with chronic hepatitis C compared with a matched general population: a nationwide register study.慢性丙型肝炎患者与普通人群相比的病假和残疾抚恤金：一项全国性登记研究。
BMJ Open. 2020 Sep 2;10(9):e035996. doi: 10.1136/bmjopen-2019-035996.
3
Cost-effectiveness analysis of treatment timing considering the future entry of lower-cost generics for hepatitis C.考虑到未来低成本丙型肝炎仿制药进入市场时治疗时机的成本效益分析。
Clinicoecon Outcomes Res. 2018 Sep 20;10:539-550. doi: 10.2147/CEOR.S171248. eCollection 2018.
4
An innovative approach to increase viral hepatitis diagnoses and linkage to care using opt-out testing and an integrated care pathway in a London Emergency Department.一种创新方法，通过选择退出检测和整合护理途径，在伦敦急诊部门增加病毒性肝炎诊断和护理联系。
PLoS One. 2018 Jul 25;13(7):e0198520. doi: 10.1371/journal.pone.0198520. eCollection 2018.
5
Scenarios to manage the hepatitis C disease burden and associated economic impact of treatment in Turkey.土耳其丙型肝炎疾病负担及治疗相关经济影响的管理方案。
Hepatol Int. 2017 Nov;11(6):509-516. doi: 10.1007/s12072-017-9820-3. Epub 2017 Oct 12.
6
Does the Strategy of Risk Group Testing for Hepatitis C Hit the Target?丙型肝炎风险群体检测策略是否达到目标？
Front Pharmacol. 2017 Jun 30;8:437. doi: 10.3389/fphar.2017.00437. eCollection 2017.
7
Labour productivity losses caused by premature death associated with hepatitis C in Spain.西班牙丙型肝炎相关过早死亡导致的劳动生产率损失。
Eur J Gastroenterol Hepatol. 2015 Jun;27(6):631-7. doi: 10.1097/MEG.0000000000000336.
8
Predicting the impact of adverse events and treatment duration on medical resource utilization-related costs in hepatitis C genotype 1 treatment-naïve patients receiving antiviral therapy.预测不良事件和治疗持续时间对接受抗病毒治疗的初治丙型肝炎基因1型患者医疗资源利用相关成本的影响。
Pharmacoeconomics. 2015 Apr;33(4):409-22. doi: 10.1007/s40273-014-0249-4.